Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger

ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger

  • May 29, 2026

Eli Lilly took to the stage at the American Society of Clinical Oncology meeting in Chicago to share early data for a new drug candidate that could, if all goes right, challenge the dominance of Pfizer and Astellas Pharma’s Padcev in bladder cancer.

Leave A Comment

Fields (*) Mark are Required